Related Experiment Videos

[Risk factors and coronary heart disease prevention in selected Lódź population--Part I]

Jan Kowalski1, Jolanta Gburek, Małgorzata Kos

  • 1Katedra Rehabilitacji z Klinika Chorób Wewnetrznych i Rehabilitacji Kardiologicznej Szpitala Klinicznego Nr 5 UM w Lodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|March 9, 2006
PubMed

Insights

Cardiovascular disease prevention is insufficient in Lódź, Poland. High rates of obesity, high cholesterol, and hypertension were found in both patients with and without coronary heart disease (CHD).

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Effective primary and secondary prevention of coronary heart disease (CHD) relies on accurate assessment and mitigation of atherosclerosis risk factors.

Purpose of the Study:

  • To assess the prevalence of atherosclerosis risk factors in individuals with and without diagnosed CHD residing in Lódź, Poland.
  • To evaluate the effectiveness of current prevention strategies for cardiovascular diseases in the Lódź population.

Main Methods:

  • A comparative study involving two groups: Group I (196 patients with CHD) and Group II (170 subjects without CHD).
  • Demographic data (age, sex) and prevalence of key risk factors including overweight/obesity, elevated total cholesterol, hypertension, smoking, and diabetes were recorded for both groups.

Main Results:

  • Overweight or obesity was the most prevalent risk factor in both groups (74.49% in Group I, 60% in Group II).
  • Other significant risk factors in Group I included elevated total cholesterol (65.08%), hypertension (51.53%), smoking (40.31%), and diabetes (24.08%).
  • Group II exhibited lower but still substantial prevalence: smoking (48.82%), elevated total cholesterol (43.53%), hypertension (40.24%), and diabetes (16.98%).

Conclusions:

  • The study indicates that the implementation of primary and secondary prevention strategies for cardiovascular diseases in the Lódź population is inadequate.
  • There is a clear need for improved public health initiatives and clinical interventions to manage atherosclerosis risk factors in this region.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...